RESEARCH-USE BIOSIMILAR ANTIBODY
Zalifrelimab
Monoclonal antibody · IgG1
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.
TARGETCTLA4
YMonoclonal antibody
CATALOGSC-BS-022
CATALOG NUMBERSC-BS-022
MOLECULAR WEIGHTApprox. 144.48 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.
Zalifrelimab is a recombinant research-use antibody directed against CTLA4.